Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

To track or not to track: wheeze phenotypes in preschool children

Paul L.P. Brand, André Schultz
European Respiratory Journal 2018 51: 1800042; DOI: 10.1183/13993003.00042-2018
Paul L.P. Brand
1Isala Women and Children's Hospital, Zwolle, the Netherlands
2UMCG Postgraduate School of Medicine, University Medical Centre and University of Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Schultz
3Telethon Kids Institute, University of Western Australia, Perth, Australia
4Dept of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Wheeze phenotypes in preschool children are insufficiently stable and valid to base treatment decisions upon http://ow.ly/HFhd30ivJyq

To the Editor:

We applaud the robust statistical approach used by Spycher et al. [1] to assess the temporal stability of episodic viral wheeze (EVW) and multitrigger wheeze (MTW) phenotypes in young children. They reported that in two large population-based cohort studies, children who continued to wheeze at 4 and 6 years of age showed a tendency to maintain the same phenotype from the age of 2 years. The authors' conclusion, and that of the accompanying editorial, is that the EVW and MTW phenotypes in young children are stable and track over time [2], and that these phenotypes may represent different disease entities [1, 2]. We would like to call for caution in interpreting these results because they are based on statistical probability, not on clinical differential diagnosis.

The statistical analysis that the authors have used examines whether crossover between phenotypes is due to chance or whether there is any tendency to track. If the phenotype at follow-up had nothing to do with the phenotype at baseline (except for its severity, which was adjusted for because it is known that severe wheeze tends to persist), then phenotype distribution at follow-up would not differ from chance, with each phenotype appearing with a probability equal to its prevalence. The data of Spycher et al. [1] showed that this was not the case: the odds ratios of remaining in the EVW and MTW phenotypes between the ages of 2 and 4 years were 4.9–9.4 and 12.9–20.5, respectively [1]. Whilst this convincingly shows that the likelihood of phenotype persistence is larger than one would expect based on chance alone, it does not rule out or contradict phenotype switching over time, which has been described previously [3, 4].

First, the authors show that the majority of preschool-aged children with EVW and MTW will not have either EVW or MTW 2 years later as they will have become asymptomatic over time. This is in agreement with earlier population studies [5]. Second, figure 1 in the paper article by Spycher et al. [1] shows that ∼10% of the 2-year-olds with MTW cross over to EVW and ∼20% of the 2-year-olds with EVW cross over to MTW by the age of 4 years. These crossover proportions are lower than those in our original publication on the topic in 2010, in which we followed up preschool children treated in hospital-based paediatric practice with inhaled corticosteroids (ICS) for 1 year [3]. It appears, therefore, that phenotype changes in preschool children with recurrent wheeze do occur, and that such changes are more common in children treated with ICS for wheezing in primary and secondary care [3, 4] than they are at general population level [1].

Although the results of Spycher et al. [1] suggest that the pathophysiology of EVW and MTW may differ [1], we believe their findings should not yet lead to a different approach in the treatment of preschool wheeze. There is consensus among clinicians and researchers that the severity and frequency of wheeze symptoms determine the need for daily controller therapy in preschool children with recurrent wheezing [6]. There is convincing evidence from a large number of valid randomised controlled trials that ICS reduce the frequency and severity of wheeze episodes in preschool children with recurrent wheeze, independent of wheeze phenotype [7]. Adherence to ICS is the single most important determinant of asthma control in preschool children with recurrent wheeze [8]. By contrast, montelukast has not been shown to be effective in reducing wheeze episodes in preschool children with recurrent wheezing [9].

The relatively high remission rate in preschool children with EVW in the general population cohort of Spycher et al. [1] should not lead to therapeutic nihilism in patients with this condition. The likelihood of long-term remission is considerably lower in patients referred to hospital-based paediatric practice because of more severe symptoms [10]. These patients do have troublesome symptomatic wheezing that responds to daily controller therapy [7, 8].

In conclusion, whilst the landmark study by Spycher et al. [1] shows a statistical likelihood larger than chance of phenotype persistence in preschool children with recurrent wheezing, a considerable minority of children with a given phenotype at the age of 2 years will switch to another phenotype at the age of 4 years if they remain symptomatic, and the majority will not remain symptomatic. As the accompanying editorial states, the overall prognostic value of the EVW–MTV classification is low [2]. As much as we would love to be able to predict which preschool wheezers become “true asthmatics” by the age of 6 years, the EVW–MTW phenotype distinction does not allow this, and it should therefore not be used as a basis for decisions on long-term daily controller therapy in these patients. The frequency and severity of wheeze symptoms in preschool children should remain the key considerations in the decision to prescribe daily preventer therapy in preschool children with recurrent troublesome wheezing [6], and ICS remain the preferred treatment option in preschool children with wheeze of sufficient severity to warrant such daily controller therapy, irrespective of wheeze phenotype [6, 7].

Footnotes

  • Conflict of interest: None declared.

  • Received January 7, 2018.
  • Accepted January 29, 2018.
  • Copyright ©ERS 2018

References

  1. ↵
    1. Spycher BD,
    2. Cochrane C,
    3. Granell R, et al.
    Temporal stability of multitrigger and episodic viral wheeze in early childhood. Eur Respir J 2017; 50: 1700014.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Caudri D
    . Multi-trigger and viral wheeze: describing symptoms or defining diseases? Eur Respir J 2017; 50: 1701283.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Schultz A,
    2. Devadason SG,
    3. Savenije OE, et al.
    The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze. Acta Paediatr 2010; 99: 56–60.
    OpenUrlPubMedWeb of Science
  4. ↵
    1. van Wonderen KE,
    2. Geskus RB,
    3. van Aalderen WM, et al.
    Stability and predictiveness of multiple trigger and episodic viral wheeze in preschoolers. Clin Exp Allergy 2016; 46: 837–847.
    OpenUrl
  5. ↵
    1. Savenije OE,
    2. Kerkhof M,
    3. Koppelman GH, et al.
    Predicting who will have asthma at school age among preschool children. J Allergy Clin Immunol 2012; 130: 325–331.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Brand PL,
    2. Caudri D,
    3. Eber E, et al.
    Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J. 2014; 43: 1172–1177.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Kaiser SV,
    2. Huynh T,
    3. Bacharier LB, et al.
    Preventing exacerbations in preschoolers with recurrent wheeze: a meta-analysis. Pediatrics 2016; 137: e20154496.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Klok T,
    2. Kaptein AA,
    3. Duiverman EJ, et al.
    It's the adherence, stupid (that determines asthma control in preschool children)! Eur Respir J 2014; 43: 783–791.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Hussein HR,
    2. Gupta A,
    3. Broughton S, et al.
    A meta-analysis of montelukast for recurrent wheeze in preschool children. Eur J Pediatr 2017; 176: 963–969.
    OpenUrl
  10. ↵
    1. Kappelle L,
    2. Brand PL
    . Severe episodic viral wheeze in preschool children: high risk of asthma at age 5–10 years. Eur J Pediatr 2012; 171: 947–954.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
View this article with LENS
Vol 51 Issue 4 Table of Contents
European Respiratory Journal: 51 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
To track or not to track: wheeze phenotypes in preschool children
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
To track or not to track: wheeze phenotypes in preschool children
Paul L.P. Brand, André Schultz
European Respiratory Journal Apr 2018, 51 (4) 1800042; DOI: 10.1183/13993003.00042-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
To track or not to track: wheeze phenotypes in preschool children
Paul L.P. Brand, André Schultz
European Respiratory Journal Apr 2018, 51 (4) 1800042; DOI: 10.1183/13993003.00042-2018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Correspondence

  • Clinical outcomes of bronchiectasis in India
  • Reply: Clinical outcomes of bronchiectasis in India
  • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society